Liraglutide in Spinal Fluid

N/ACompletedNCT02104037

Mikkel Christensen8 enrolled

Overview

The purpose of this study is to investigate transfer of liraglutide from blood to cerebrospinal fluid.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

NONE

Enrollment

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Type 2 diabetes treated with liraglutide 1.8 mg for 1 month and 5% weight loss Exclusion Criteria: \-

Diabetes Research Division, Department of Medicine

Hellerup, Denmark

cerebrospinal fluid concentration of liraglutide

Time frame: time 60 minutes

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.